Granuloma annulare associated with Hodgkin's disease.
Setoyama
M
M
Department of Dermatology, Faculty of Medicine, Kagoshima University, Japan.
Kerdel
F A
FA
Byrnes
J J
JJ
Kanzaki
T
T
D000273:Adipose Tissue / Q000473:pathology; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003094:Collagen; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D015726:Giant Cells / Q000473:pathology; D016460:Granuloma Annulare / Q000150:complications* / Q000473:pathology; D006644:Histiocytes / Q000473:pathology; D006689:Hodgkin Disease / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008214:Lymphocytes / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D016539:Reed-Sternberg Cells / Q000473:pathology; D012867:Skin / Q000473:pathology; D014747:Vinblastine / Q000008:administration & dosage
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D003094:Collagen